Back to Journals » Biologics: Targets and Therapy » Volume 9

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

Total article views   HTML views PDF downloads Totals
9,555 Dovepress* 9,140+ 1,738 10,878
PubMed Central* 415 135 550
Totals 9,555 1,873 11,428
*Since 19 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar